Holen Sie sich die Stockscreener-App
25.68
6.73%
1.62
Handel nachbörslich:
25.68
Schlusskurs vom Vortag:
$24.06
Offen:
$24.29
24-Stunden-Volumen:
709.83K
Relative Volume:
1.27
Marktkapitalisierung:
$1.23B
Einnahmen:
$151.91M
Nettoeinkommen (Verlust:
$-46.03M
KGV:
-25.43
EPS:
-1.01
Netto-Cashflow:
$5.65M
1W Leistung:
+21.76%
1M Leistung:
+16.99%
6M Leistung:
-5.38%
1J Leistung:
-3.17%
1-Tages-Spanne:
$24.04
$25.73
1-Wochen-Bereich:
$20.27
$25.73
52-Wochen-Spanne:
$19.10
$29.55
Biolife Solutions Inc Stock (BLFS) Company Profile
Firmenname
Biolife Solutions Inc
Sektor
Telefon
(425) 401-1400
Adresse
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Vergleichen Sie BLFS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
25.68 | 1.15B | 151.91M | -46.03M | 5.65M | -1.01 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2024-09-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-04-25 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-05-14 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Eingeleitet | Cowen | Outperform |
| 2020-08-11 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Bestätigt | Maxim Group | Buy |
| 2020-02-24 | Eingeleitet | Lake Street | Buy |
| 2020-02-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Fortgesetzt | B. Riley FBR | Buy |
| 2020-01-08 | Eingeleitet | Stephens | Overweight |
| 2019-11-21 | Eingeleitet | Oppenheimer | Outperform |
| 2019-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-11-10 | Bestätigt | Maxim Group | Buy |
| 2017-09-19 | Bestätigt | Maxim Group | Buy |
| 2017-07-05 | Hochstufung | Janney | Neutral → Buy |
| 2017-03-10 | Bestätigt | Maxim Group | Buy |
| 2017-01-19 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Biolife Solutions Inc Aktie (BLFS) Neueste Nachrichten
Casdin Partners sells BioLife Solutions NASDAQ:BLFS shares for $11.3m - Investing.com
BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why - MSN
BioLife (BLFS) Is Up 16.1% After Raising 2025 Guidance and Reporting Strong Q2 Results - simplywall.st
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know - sharewise.com
BioLife Solutions Reports Strong Q2 Growth Amid Challenges - TipRanks
BioLife Solutions, Inc. (NASDAQ:BLFS) Q2 2025 Earnings Call Transcript - Insider Monkey
Analysts Weigh In on Green Thumb Industries, Doximity, and BioLife Solutions - AInvest
BioLife Solutions raises 2025 revenue guidance to $100M–$103M as cell processing momentum accelerates - MSN
BioLife Solutions Reports Strong Q2 2025 Growth - TipRanks
What You Can Learn From BioLife Solutions, Inc.'s (NASDAQ:BLFS) P/S - 富途牛牛
BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025 - goSkagit
Regression analysis insights on BioLife Solutions Inc. performanceAI Intraday Market Movement Prediction Tool - Newser
Will BioLife Solutions Inc. rebound enough to break evenWeekly Stock Market Strategy Summary - Newser
BioLife Solutions (NASDAQ:BLFS) Receives “Buy” Rating from HC Wainwright - Defense World
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2 - MSN
A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $30 to $32 - 富途牛牛
BioLife Solutions Receives Buy Rating from Northland Securities, Price Target at $31.00 - AInvest
BioLife Solutions (BLFS) Is Up 9.0% After Raising 2025 Revenue Outlook Has The Bull Case Changed? - simplywall.st
BioLife Solutions Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Is BioLife Solutions (NASDAQ:BLFS) A Risky Investment? - simplywall.st
BioLife Solutions (NASDAQ:BLFS) Trading 12.5% Higher on Analyst Upgrade - Defense World
How to use a screener to detect BioLife Solutions Inc. breakoutsDaily Trade Monitor with Pattern Alerts - Newser
Can you recover from losses in BioLife Solutions Inc.Smart Trade Forecast Based on Neural Logic - Newser
BioLife Solutions 2025 Q2 Earnings Loss Narrows 23.6% as Revenue Rises 28.9% - AInvest
BioLife Solutions Raises 2025 Revenue Guidance to $100M-$103M on Cell Processing Momentum - AInvest
BioLife Solutions: HC Wainwright Raises PT to $32, Maintains Buy Rating - AInvest
Earnings call transcript: BioLife Solutions Q2 2025 sees EPS miss, raises revenue guidance - Investing.com Nigeria
BioLife Solutions Inc reports results for the quarter ended June 30Earnings Summary - TradingView
BioLife Solutions: Strong Performance and Growth Potential with Buy Rating - TipRanks
BioLife Solutions: Strategic Reinvention and Growth in the Biopreservation Sector - AInvest
BioLife Solutions Updates 2025 Revenue Guidance to $100-103mln, Reflecting 22-25% YoY Growth - AInvest
BioLife Solutions earnings missed by $0.30, revenue topped estimates - Investing.com Canada
BioLife Solutions Q2 revenue up 28% YoY to $23mln, raises FY23 guidance. - AInvest
BioLife Solutions Reports Second Quarter 2025 Financial Results - TradingView
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $25.4M, vs. FactSet Est of $23.7M - MarketScreener
Market reaction to BioLife Solutions Inc.’s recent newsReliable Setup Screener with Low Risk - Newser
BioLife Solutions, Inc. (NASDAQ:BLFS) Receives Consensus Rating of “Buy” from Analysts - Defense World
BioLife Solutions BLFS 2025Q2 Earnings Preview Upside Anticipated on Robust Revenue Growth - AInvest
Is BioLife Solutions Inc. the Top Chart Pick This WeekEarly Breakout Entry Point Notifications Sent - beatles.ru
BioLife Solutions Inc. Approaches Psychological Resistance LevelDay Trading Signals With High Precision Reviewed - metal.it
How volatile is BioLife Solutions Inc. stock compared to the marketUnlock daily market insights for better trades - Jammu Links News
What makes BioLife Solutions Inc. stock price move sharplyExplosive earnings growth - Jammu Links News
Is BioLife Solutions Inc. stock overvalued or undervaluedMaximize portfolio growth with strategic plans - Jammu Links News
How many analysts rate BioLife Solutions Inc. as a “Buy”Build wealth with long-term growth strategies - Jammu Links News
What catalysts could drive BioLife Solutions Inc. stock higher in 2025Rapid profit acceleration - Jammu Links News
What are BioLife Solutions Inc. company’s key revenue driversFree Risk Assessment Services - Jammu Links News
Reversal indicators forming on BioLife Solutions Inc. stockReversal Pattern Insights with Entry Tips - Newser
BioLife Solutions Inc. Stock Analysis and ForecastBreakneck growth rates - Jammu Links News
Contrasting GlucoTrack (NASDAQ:GCTK) & BioLife Solutions (NASDAQ:BLFS) - Defense World
Candlestick signals on BioLife Solutions Inc. stock todayTechnical Screener for High Growth Stocks - Newser
Why is BioLife Solutions Inc. stock attracting strong analyst attentionInvest in stocks with strong fundamentals - Jammu Links News
Finanzdaten der Biolife Solutions Inc-Aktie (BLFS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):